Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khuri

Showing results (871-880 of 969) with videos related to

Pageof 97
Sort By:
Vaccine|October 12, 2014
The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG)Robert T Chen, Baevin Carbery, Lisa Mac, et al.
The Journal of Biological Chemistry|August 9, 2014
Tyr-301 phosphorylation inhibits pyruvate dehydrogenase by blocking substrate binding and promotes the Warburg effectJun Fan, Hee-Bum Kang, Changliang Shan, et al.
Journal of Translational Medicine|May 5, 2016
Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancerTaofeek K Owonikoko, Guojing Zhang, Hyun S Kim, et al.
Cancer|February 7, 2014
A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non-small cell lung cancer after failure of prior chemotherapy and erlotinibKaren L Reckamp, Giuseppe Giaccone, D Ross Camidge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trialD M Shin, F R Khuri, B Murphy, et al.
Journal of the National Cancer Institute|February 6, 2003
Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized placebo-controlled trialJonathan M Kurie, Reuben Lotan, J Jack Lee, et al.
Molecular Cell|December 19, 2017
The PLAG1-GDH1 Axis Promotes Anoikis Resistance and Tumor Metastasis through CamKK2-AMPK Signaling in LKB1-Deficient Lung CancerLingtao Jin, Jaemoo Chun, Chaoyun Pan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: toxicities and responsesA S Garden, B S Glisson, K K Ang, et al.
Thyroid : Official Journal of the American Thyroid Association|June 1, 2013
Randomized safety and efficacy study of fosbretabulin with paclitaxel/carboplatin against anaplastic thyroid carcinomaJulie A Sosa, Rossella Elisei, Barbara Jarzab, et al.
Annals of Surgery|October 28, 1998
The Department of Veterans Affairs' NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA Surgical Quality Improvement ProgramS F Khuri, J Daley, W Henderson, et al.
Pageof 97

Showing results (871-880 of 969) with videos related to

Sort By:
Pageof 97
Vaccine|October 12, 2014
The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG)Robert T Chen, Baevin Carbery, Lisa Mac, et al.
The Journal of Biological Chemistry|August 9, 2014
Tyr-301 phosphorylation inhibits pyruvate dehydrogenase by blocking substrate binding and promotes the Warburg effectJun Fan, Hee-Bum Kang, Changliang Shan, et al.
Journal of Translational Medicine|May 5, 2016
Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancerTaofeek K Owonikoko, Guojing Zhang, Hyun S Kim, et al.
Cancer|February 7, 2014
A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non-small cell lung cancer after failure of prior chemotherapy and erlotinibKaren L Reckamp, Giuseppe Giaccone, D Ross Camidge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trialD M Shin, F R Khuri, B Murphy, et al.
Journal of the National Cancer Institute|February 6, 2003
Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized placebo-controlled trialJonathan M Kurie, Reuben Lotan, J Jack Lee, et al.
Molecular Cell|December 19, 2017
The PLAG1-GDH1 Axis Promotes Anoikis Resistance and Tumor Metastasis through CamKK2-AMPK Signaling in LKB1-Deficient Lung CancerLingtao Jin, Jaemoo Chun, Chaoyun Pan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: toxicities and responsesA S Garden, B S Glisson, K K Ang, et al.
Thyroid : Official Journal of the American Thyroid Association|June 1, 2013
Randomized safety and efficacy study of fosbretabulin with paclitaxel/carboplatin against anaplastic thyroid carcinomaJulie A Sosa, Rossella Elisei, Barbara Jarzab, et al.
Annals of Surgery|October 28, 1998
The Department of Veterans Affairs' NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA Surgical Quality Improvement ProgramS F Khuri, J Daley, W Henderson, et al.
Pageof 97